Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy

ESC Heart Fail. 2017 Nov;4(4):641-644. doi: 10.1002/ehf2.12175. Epub 2017 Jul 25.

Abstract

Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with heart failure due to left ventricular systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause of heart failure is found. We report a case of a woman with PPCM who developed a critical cardiogenic shock with repeated cardiopulmonary resuscitation. We show for the first time that mechanical circulatory support combined with high-dose bromocriptine therapy to suppress systemic prolactin levels may serve as an effective therapeutic option in patients with fulminant PPCM and cardiogenic shock. Myocardial cathepsin D was overexpressed in our patient underscoring a potential role of cathepsin D-induced cleavage of prolactin in the pathophysiology of PPCM.

Keywords: Bromocriptine; Cathepsin D; ECLS; Peripartum cardiomyopathy; Prolactin.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Bromocriptine / administration & dosage*
  • Cardiomyopathies / complications*
  • Cardiomyopathies / therapy
  • Dopamine Agonists / administration & dosage
  • Dose-Response Relationship, Drug
  • Female
  • Heart-Assist Devices*
  • Humans
  • Peripartum Period*
  • Recovery of Function*
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / therapy*

Substances

  • Dopamine Agonists
  • Bromocriptine